Biotech

All Articles

Analysts dig into Avidity's DMD gain, disclosing nuances in records

.Avidity Biosciences pleased clients with phase 1/2 records in Duchenne muscular dystrophy (DMD) Fri...

Actinogen's cortisol blocker fails stage 2 depression research

.Actinogen Medical's cortisol blocker has actually overlooked the key endpoint of a period 2 researc...

Bivictrix makes a decision going exclusive only means to take ADC into medical clinic

.Antibody-drug conjugates (ADCs) have gone to the facility of a lot of a billion-dollar biobuck lice...

TPG bests up funds to $580M for investments throughout life sciences

.Resource manager TPG, which has actually sustained biotechs such as Sionna Therapeutics and also Sa...

Merck ceases stage 3 TIGIT trial in lung cancer cells for futility

.Merck &amp Co.'s TIGIT course has actually suffered another obstacle. Months after shuttering a per...

After a hard year, Exscientia folds right into Recursion

.After a year described through pipeline cuts, the departure of its own chief executive officer and ...

Cullinan, after $25M deal, hands back bispecific to Harbour

.Cullinan Rehab was made an impression on good enough with Harbour BioMed's bispecific immune reacto...

A closer consider Intense Biotech's Tough 15

.Within this full week's episode of "The Top Line," our team're diving into Tough Biotech's yearly F...

Lilly deals with phase 2 breakdown of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's party commemorating the approval of Alzheimer...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable management hirings, firings and also ...